461 related articles for article (PubMed ID: 17275432)
1. CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.
Liu F; Lee SK; Adams DJ; Gronowicz GA; Kream BE
Bone; 2007 Apr; 40(4):1135-43. PubMed ID: 17275432
[TBL] [Abstract][Full Text] [Related]
2. Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2.
Ferrari SL; Pierroz DD; Glatt V; Goddard DS; Bianchi EN; Lin FT; Manen D; Bouxsein ML
Endocrinology; 2005 Apr; 146(4):1854-62. PubMed ID: 15705780
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy-associated plasma protein-A modulates the anabolic effects of parathyroid hormone in mouse bone.
Clifton KB; Conover CA
Bone; 2015 Dec; 81():413-416. PubMed ID: 26297833
[TBL] [Abstract][Full Text] [Related]
4. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in mice.
Choudhary S; Canalis E; Estus T; Adams D; Pilbeam C
PLoS One; 2015; 10(3):e0120164. PubMed ID: 25781979
[TBL] [Abstract][Full Text] [Related]
6. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
[TBL] [Abstract][Full Text] [Related]
7. Are osteoclasts needed for the bone anabolic response to parathyroid hormone? A study of intermittent parathyroid hormone with denosumab or alendronate in knock-in mice expressing humanized RANKL.
Pierroz DD; Bonnet N; Baldock PA; Ominsky MS; Stolina M; Kostenuik PJ; Ferrari SL
J Biol Chem; 2010 Sep; 285(36):28164-73. PubMed ID: 20558734
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
[TBL] [Abstract][Full Text] [Related]
9. Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.
Xu M; Choudhary S; Voznesensky O; Gao Q; Adams D; Diaz-Doran V; Wu Q; Goltzman D; Raisz LG; Pilbeam CC
Bone; 2010 Aug; 47(2):341-52. PubMed ID: 20471507
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin induces expression of the inducible cAMP early repressor in osteoclasts.
Yang M; Kream BE
Endocrine; 2008 Jun; 33(3):245-53. PubMed ID: 19016003
[TBL] [Abstract][Full Text] [Related]
11. Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone.
Yang D; Singh R; Divieti P; Guo J; Bouxsein ML; Bringhurst FR
Bone; 2007 Jun; 40(6):1453-61. PubMed ID: 17376756
[TBL] [Abstract][Full Text] [Related]
12. Differential transcriptional effects of PTH and estrogen during anabolic bone formation.
von Stechow D; Zurakowski D; Pettit AR; Müller R; Gronowicz G; Chorev M; Otu H; Libermann T; Alexander JM
J Cell Biochem; 2004 Oct; 93(3):476-90. PubMed ID: 15372627
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH.
Merciris D; Schiltz C; Legoupil N; Marty-Morieux C; de Vernejoul MC; Geoffroy V
Bone; 2007 Jan; 40(1):75-83. PubMed ID: 16949899
[TBL] [Abstract][Full Text] [Related]
14. Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats.
Schmitt CP; Hessing S; Oh J; Weber L; Ochlich P; Mehls O
Kidney Int; 2000 Apr; 57(4):1484-92. PubMed ID: 10760084
[TBL] [Abstract][Full Text] [Related]
15. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
16. Nmp4/CIZ suppresses the response of bone to anabolic parathyroid hormone by regulating both osteoblasts and osteoclasts.
Childress P; Philip BK; Robling AG; Bruzzaniti A; Kacena MA; Bivi N; Plotkin LI; Heller A; Bidwell JP
Calcif Tissue Int; 2011 Jul; 89(1):74-89. PubMed ID: 21607813
[TBL] [Abstract][Full Text] [Related]
17. Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone.
Tamasi JA; Vasilov A; Shimizu E; Benton N; Johnson J; Bitel CL; Morrison N; Partridge NC
J Bone Miner Res; 2013 Sep; 28(9):1975-86. PubMed ID: 23519994
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.
Feng Y; Zhou M; Zhang Q; Liu H; Xu Y; Shu L; Zhang J; Miao D; Ren Y
Br J Nutr; 2015 Mar; 113(6):909-22. PubMed ID: 25744000
[TBL] [Abstract][Full Text] [Related]
19. Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice.
Yamaguchi M; Ogata N; Shinoda Y; Akune T; Kamekura S; Terauchi Y; Kadowaki T; Hoshi K; Chung UI; Nakamura K; Kawaguchi H
Endocrinology; 2005 Jun; 146(6):2620-8. PubMed ID: 15718274
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation.
Kitahara K; Ishijima M; Rittling SR; Tsuji K; Kurosawa H; Nifuji A; Denhardt DT; Noda M
Endocrinology; 2003 May; 144(5):2132-40. PubMed ID: 12697722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
